FDA approves pill to treat postpartum depression – CBS News

Watch CBS News

For the first time, the FDA has approved a pill for women dealing with postpartum depression that’s expected to be available after a 90-day review. Clinical trial data shows the drug, called zuranolone, eases depression in a few days, faster than other antidepressants. CBS News medical contributor Dr. Celine Gounder explains how it works, what the side effects could be and more.

Be the first to know

Get browser notifications for breaking news, live events, and exclusive reporting.